Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAISE trial of prednisone/prednisolone for acute interstitial nephritis
2024-520299-86-00Phase 4Authorised
- Sponsor
- Central Denmark Region
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in Acute tubulointerstitial nephritis (ATIN) (2 arms), sponsored by Central Denmark Region. Primary endpoint: eGFR at 3 months. Planned start Jan 2025; status: authorised.
02
Drugs
prednisolone
03
Conditions
Acute tubulointerstitial nephritis (ATIN)
Beyond the preview
Go deeper on 2024-520299-86-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520299-86-00.